Home Newsfeeds Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

Carvana Stock Cruises On Q3 Earnings: Nearly 81k Vehicles Sold, Gross Profit Per Vehicle Jumps Despite ‘Challenging Industry Environment’

By Adam Eckert

November 2, 4:41 PM

Carvana Co (NYSE: CVNA) reported third-quarter financial results Thursday after the close.

CVNA

Citigroup Initiates Coverage On AvePoint with Neutral Rating, Announces Price Target of $4.5

By Benzinga Newsdesk

November 4, 9:10 AM

Citigroup analyst Fatima Boolani initiates coverage on AvePoint (NASDAQ:AVPT) with a Neutral rating and announces Price Target of $4.5.

AVPT

Vertex To Present New Data Demonstrating Significant Benefits Of Treatment With TRIKAFTA At The ECFS 47th European Cystic Fibrosis Conference Held June 5-8, 2024

By Benzinga Newsdesk

June 7, 12:03 PM

- Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR mutations showed statistically significant and clinically meaningful improvements in the

VRTX

Survey Finds Apple Car Captures Significant Mindshare Even Before Launch: Should Automakers Fear?

By Shanthi Rexaline

September 4, 3:37 PM

Apple, Inc. (NASDAQ: AAPPL) could be a winner with its self-driving car when it finally rolls one out, according to the results of a survey.

AAPL

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Related Posts

Carvana Stock Cruises On Q3 Earnings: Nearly 81k Vehicles Sold, Gross Profit Per Vehicle Jumps Despite ‘Challenging Industry Environment’

Citigroup Initiates Coverage On AvePoint with Neutral Rating, Announces Price Target of $4.5

Vertex To Present New Data Demonstrating Significant Benefits Of Treatment With TRIKAFTA At The ECFS 47th European Cystic Fibrosis Conference Held June 5-8, 2024

Survey Finds Apple Car Captures Significant Mindshare Even Before Launch: Should Automakers Fear?